- Home
- Publications
- Publication Search
- Publication Details
Title
COVID-19 and Its Implications for Thrombosis and Anticoagulation
Authors
Keywords
-
Journal
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
Volume -, Issue -, Pages -
Publisher
Georg Thieme Verlag KG
Online
2021-02-09
DOI
10.1055/s-0041-1722992
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Increased Risk of Death in Acutely Ill Medical Patients with Asymptomatic Proximal Deep Vein Thrombosis or Symptomatic Venous Thromboembolism: Insights from the Magellan Study
- (2020) Gary E. Raskob et al. BLOOD
- Abnormal Coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia
- (2020) Ning Tang et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome: Results From a Prospective, Single-Center, Clinicopathologic Case Series
- (2020) Sigurd F. Lax et al. ANNALS OF INTERNAL MEDICINE
- Autopsy Findings and Venous Thromboembolism in Patients With COVID-19
- (2020) Dominic Wichmann et al. ANNALS OF INTERNAL MEDICINE
- Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis
- (2020) Zhikang Ye et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study
- (2020) Julie Helms et al. INTENSIVE CARE MEDICINE
- Association of inflammatory markers with the severity of COVID-19: a meta-analysis
- (2020) Furong Zeng et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Convalescent Plasma to Treat COVID-19
- (2020) John D. Roback et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
- (2020) Chenguang Shen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Tocilizumab for the treatment of severe coronavirus disease 2019
- (2020) Rand Alattar et al. JOURNAL OF MEDICAL VIROLOGY
- Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19
- (2020) Ishan Paranjpe et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Tissue plasminogen activator (tPA) treatment for COVID‐19 associated acute respiratory distress syndrome (ARDS): A case series
- (2020) Janice Wang et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Direct oral anticoagulant plasma levels’ striking increase in severe COVID‐19 respiratory syndrome patients treated with antiviral agents: The Cremona experience
- (2020) Sophie Testa et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Scientific and Standardization Committee Communication: Clinical Guidance on the Diagnosis, Prevention and Treatment of Venous Thromboembolism in Hospitalized Patients with COVID‐19
- (2020) Alex C. Spyropoulos et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Hypercoagulability of COVID‐19 patients in Intensive Care Unit. A Report of Thromboelastography Findings and other Parameters of Hemostasis
- (2020) Mauro Panigada et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Macrothrombosis and stroke in patients with mild Covid‐19 infection
- (2020) Michael G. Fara et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- High incidence of venous thromboembolic events in anticoagulated severe COVID‐19 patients
- (2020) Jean‐François Llitjos et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Incidence of venous thromboembolism in hospitalized patients with COVID‐19
- (2020) Saskia Middeldorp et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia
- (2020) Songping Cui et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Acute limb ischemia in patients with COVID-19 pneumonia
- (2020) Raffaello Bellosta et al. JOURNAL OF VASCULAR SURGERY
- Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
- (2020) Yeming Wang et al. LANCET
- Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
- (2020) Maximilian Ackermann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19
- (2020) Louise Bowles et al. NEW ENGLAND JOURNAL OF MEDICINE
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
- (2020) Bin Cao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19
- (2020) Yan Zhang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young
- (2020) Thomas J. Oxley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effective treatment of severe COVID-19 patients with tocilizumab
- (2020) Xiaoling Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effectiveness of convalescent plasma therapy in severe COVID-19 patients
- (2020) Kai Duan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19
- (2020) Wenhua Liang et al. JAMA Internal Medicine
- Post-discharge venous thromboembolism following hospital admission with COVID-19
- (2020) Lara N Roberts et al. BLOOD
- Post-discharge thrombosis and hemorrhage in patients with COVID-19
- (2020) Rushad Patell et al. BLOOD
- Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19
- (2020) Ling Li et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The hazard of (sub)therapeutic doses of anticoagulants in non‐critically ill patients with Covid‐19: the Padua province experience
- (2020) Raffaele Pesavento et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Is there a role for tissue plasminogen activator as a novel treatment for refractory COVID-19 associated acute respiratory distress syndrome?
- (2020) Hunter B. Moore et al. Journal of Trauma and Acute Care Surgery
- A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
- (2020) David R. Boulware et al. NEW ENGLAND JOURNAL OF MEDICINE
- Incidence of thrombotic complications in critically ill ICU patients with COVID-19
- (2020) F.A. Klok et al. THROMBOSIS RESEARCH
- Is a “Cytokine Storm” Relevant to COVID-19?
- (2020) Pratik Sinha et al. JAMA Internal Medicine
- Efficacy of Remdesivir in COVID-19
- (2020) Erin K. McCreary et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19
- (2020) Christoph D. Spinner et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Case 26-2020: A 60-Year-Old Woman with Altered Mental Status and Weakness on the Left Side
- (2020) Aneesh B. Singhal et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Role of Inflammation in Venous Thromboembolism
- (2018) Brian R. Branchford et al. Frontiers in Pediatrics
- Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness
- (2018) Alex C. Spyropoulos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Asymptomatic Deep Vein Thrombosis is Associated with an Increased Risk of Death: Insights from the APEX Trial
- (2018) C. Gibson et al. THROMBOSIS AND HAEMOSTASIS
- Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism
- (2017) Jeffrey I. Weitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients
- (2016) Alexander T. Cohen et al. NEW ENGLAND JOURNAL OF MEDICINE
- How I treat catastrophic thrombotic syndromes
- (2015) T. L. Ortel et al. BLOOD
- Thromboembolic events in patients with severe pandemic influenza A/H1N1
- (2015) Lone Sølling Avnon et al. European Journal of Internal Medicine
- Inflammation in venous thromboembolism: Cause or consequence?
- (2015) Amene Saghazadeh et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Current concepts in the diagnosis and management of cytokine release syndrome
- (2014) D. W. Lee et al. BLOOD
- Managing Cytokine Release Syndrome Associated With Novel T Cell-Engaging Therapies
- (2014) Shannon L. Maude et al. CANCER JOURNAL
- Anti-thrombotic effects of hydroxychloroquine in primary antiphospholipid syndrome patients
- (2013) A Schmidt-Tanguy et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical Patients
- (2013) Alexander T. Cohen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban for Extended Treatment of Venous Thromboembolism
- (2012) Giancarlo Agnelli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Therapeutic Modulation of Coagulation and Fibrinolysis in Acute Lung Injury and the Acute Respiratory Distress Syndrome
- (2011) Sara C. Sebag et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Apixaban versus Enoxaparin for Thromboprophylaxis in Medically Ill Patients
- (2011) Samuel Z. Goldhaber et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pandemic H1N1 Influenza Infection and Vascular Thrombosis
- (2010) P. E. Bunce et al. CLINICAL INFECTIOUS DISEASES
- Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug
- (2009) J. H. Rand et al. BLOOD
- The coagulation system and pulmonary endothelial function in acute lung injury
- (2008) James H. Finigan MICROVASCULAR RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search